QUOTED. 19 March 2021. Red Maxwell.
Bigfoot Biomedical secured $57M in new funding to support the commercialization of its Bigfoot Unity System, up for US FDA clearance. The system is designed for people with type 1 and type 2 diabetes who rely on multiple daily injections and will be marketed under a bundled subscription model.
“Bigfoot has been very intentional in forging strong partnerships like those we have with Abbott, Allegheny Health Network and insulin manufacturers. These partnerships are the cornerstones to achieving robust connectivity that is the first step toward our industry’s long-range vision of interoperability.” – Red Maxwell, chief marketing officer, Bigfoot Biomedical
- Find out more: Bigfoot Biomedical Secures $57M In New Funding To Support Commercialization Of Diabetes Management System
Click here for a free trial of Medtech Insight